Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Injections, Subcutaneous × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Docetaxel 265 Prednisone 217 enzalutamide 171 Leuprolide 164 Radiotherapy 157 Abiraterone Acetate 152 Magnetic Resonance Spectroscopy 144 bicalutamide 118 Goserelin 117 Androgen Antagonists 106 Radiosurgery 100 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 98 apalutamide 84 gallium 68 PSMA-11 70 abiraterone 68 Specimen Handling 68 darolutamide 58 Gonadotropin-Releasing Hormone 55 Surveys and Questionnaires 53 Biopsy 53 Radiation 52 cabazitaxel 51 Triptorelin Pamoate 50 Brachytherapy 50 Standard of Care 45 pembrolizumab 44 luprolide acetate gel depot 43 Zoledronic Acid 43 Radiotherapy, Intensity-Modulated 41 Estramustine 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03899077 2024-02-07

SAVE

Cancer Research Antwerp

Phase 2 Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡